Evaluation Charter & Mission Governance Curriculum Panel Faculty Achievements

Governance of ACE

Consultant, Medical Research & Communications

Formerly Senior Medical Consultant, Pfizer USA (1998-2000), and Medical & Research Director, Pfizer India (1974-1997). He has been a member of Several Ethics Committees. He has been a referee for British Medical Journal, Journal of Association of Physicians of India and Indian Journal of Pharmacology.

Dr. Nanivadekar is the author of "Understanding The Medicines We Take"
(Oxford University Press, 2000).

Director, Clinical Research and Regulatory Affairs), Pfizer Limited

Dr. Potkar completed his postgraduation in Pharmacology ( M.D.) and MBA from Deakin University. He became a lecturer in the Department of Pharmacology, KEM Hospital in Mumbai where he was responsible for coordinating bio-equivalence and Phase I-III clinical studies in therapeutic areas like epilepsy and malaria. He joined Pfizer in 1995 as a Medical Advisor, and has been responsible for the management of several Phase II and III global clinical development programs including studies.

As Director of clinical study management and monitoring, he has contributed in efforts to make the group a premier service provider in terms of cost, quality and timeliness. He has collaborated with industry professionals, academia and government and participated in initiatives to influence clinical research environment in the country by organizing GCP workshops.

Executive Vice President, Sciformix Technologies

Dr. Lele has a Ph.D. in Statistics from Stanford University in the U.S.A. She has 12 years of experience as a statistician and researcher in academic institutes and as a biostatistician in medical colleges/hospitals and the pharmaceutical industry, both in the U.S.A and in India.
She joined Pfizer in 1998 and has been responsible for setting up the Biometrics division in India as a unit of Pfizer Global R &D. She is currently working Executive Vice President at Sciformix Technologies .Dr. Lele is a member of several professional organizations and has several publications to her credit in statistical and medical journals.


Professor S.K.Kulkarni, M.Pharm; Ph.D; FAMS; FNASci; FIPA is a distinguished pharmaceutical scientist and educationist. He has served the university system for more than three decades with great distinction. He recently superannuated as Pro-Vice Chancellor (DUI) of Panjab University.

He has received several national and international recognitions for his outstanding contributions to neuroscience, pharmacology research and pharmaceutical education. Some of his recognitions include the prestigious UGC-Hari Om Ashram Trust National Award in Neuroscience, Fulbright visiting fellowship of the US education foundation, Ranbaxy Research Foundation Award, Acharya P.C. Ray Gold Medal, Professor G.P. Srivastava Memorial National Award, Professor B. Uvnas prize, Sir Ram Nath Chopra Oration, Sir Shriram Memorial Oration, IBRO Asia Fellowship and IDMA awards.

Dr. Kulkarni has been recently identified as one amongst the top 10 most productive Indian scientists who have immensely contributed to the global knowledge base in Science and Technology during the past ten years. He is presently the Director, Bombay College of Pharmacy, Mumbai.

Chairmen, Governing Body Bombay College Of Pharmacy

VP, R&D, Nektar Therapeutics India Pvt. Ltd.

Dr. Rao Vadlamudi, after completing M.Pharm from Andhra University, obtained an M. Sc. and Ph. D. in Pharmacology from the University of British Columbia, Vancouver, B. C. Canada. He was a reader in pharmacology at UDCT, Mumbai (1984-1989), a professor in pharmacology at BCP 1989-1990, before joining Hoechst Research Centre in 1990 as a Principle Research Scientist. He headed the Department of Pharmacology, Hoechst Research Centre up to 1998, and continued as head of Pharmacology, Quest Institute of LifeSciences of Nicholas Piramal India Limited up to April 2002. In May 2002 he joined Suven Pharmaceuticals and is responsible for Discovery Biology and Clinical Research Operations.

Dr. Rao Vadlamudi, is currently the Editor of the Indian Journal of Pharmaceutical Sciences, which is the official scientific journal of the IPA. He was a visiting scientist to the Faculty of Pharmaceutical Sciences, UBC, Canada, during 1987 and 1990, a visiting professor at BCP for the past 12 years and a Ph. D. examiner for a number of Indian Universities. He is a life member of IPA, IPS and APTI and a fellow of the Indian Pharmaceutical Association.

Managing Director, Suven Pharmaceuticals Limited

Mr. Venkat Jasti holds a Master degree in Pharmacy from Andhra University and M.S. in Industrial Pharmacy, St.John's University, NY, USA. Mr. Jasti started his career as a Production Officer in Warner Hindustan Limited and later on migrated to USA wherein he owned and operated a chain of 6 community pharmacies in the United States for 12 years. He came back to India and established Suven Pharmaceuticals Limited in the year 1989, and is the Founding Managing Director, a company which specializes in `Contract Research and Manufacturing Services (C-R-A-M-S).

Mr. Jasti has been the Past President of Indian Pharmaceutical Association, Andhra Pradesh State Branch, Chairman of Local Organizing Committee for the 52nd Indian Pharmaceutical Congress, held at Hyderabad and presently is the President of Bulk Drug Manufacturers Association, India (BDMA). Mr. Jasti is also the Chief architect for the formation of A.P. Chief Minister's task force for Pharma and member of the same wherein Centres of excellence in Manufacturing, R&D and clinical research will be set up.

Vice President, Corporate Affairs, Suven Life Sciences Limited
Venkatraman Sunder is the Vice President, Operations in Asian Clinical Trials (ACT), a business division Suven Life Sciences He leads the ACT’s world-wide strategic plan through implementing and expediting key initiatives.

He has more than 20 years of experience in service, pharmaceutical, biotech and information technology and strategic management consulting companies in a variety of capacities including corporate and M&A strategy formulation, product commercialization, clinical research and data management initiatives, investment decision making, process reengineering, organizational redesign and financial management activities.

Cost and Management Accountant (ACMA) by qualification, a Certified Management Consultant (CMC) from UK and Post Graduate in Information Technology. Has delivered lectures in various topics of interest in Strategy management, Global technology initiatives, clinical research and data management and merger and acquisition strategies.

Few of the key initiatives in Suven Life Sciences in the past 6 years by Venkatraman Sunder are:

  • Acquiring pharma company in New Jersey, USA and merging with Suven Life Sicences
  • Initiating technology alliances and collaborative research programs
  • Starting clinical research operations in USA
  • Large scale investment strategies and starting new business segments for Suven Life Sciences
Presently involved in further creation of new business segments for Suven in USA and Europe.

Copyright 2007 Academy for Clinical Excellence.   
All Rights Reserved.           Site Design  www.exitdesign.in